Barclays
GRDN icon

Barclays’s Guardian Pharmacy Services GRDN Stock Holding History

Barclays’s Portfolio GRDN Stock Details GRDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$623K Buy
15,279
+11,946
+358% +$487K ﹤0.01% 3346
2026
Q2 		$140K Sell
3,333
-1,501
-31% -$58.1K ﹤0.01% 3898
2026
Q1 		$182K Sell
4,834
-30,351
-86% -$992K ﹤0.01% 3745
2025
Q4 		$1.06M Buy
35,185
+7,212
+26% +$204K ﹤0.01% 3392
2025
Q3 		$734K Buy
27,973
+2,075
+8% +$49.5K ﹤0.01% 3565
2025
Q2 		$552K Buy
25,898
+16,964
+190% +$383K ﹤0.01% 3707
2025
Q1 		$190K Sell
8,934
-4,275
-32% -$87.7K ﹤0.01% 4070
2024
Q4 		$268K Sell
13,209
-5,291
-29% -$109K ﹤0.01% 4168
2024
Q3 		$311K Buy
+18,500
New +$312K ﹤0.01% 4062

Other funds holding GRDN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
TimesSquare Capital Management
TimesSquare Capital Management New York $6.12B AUM 30.01% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $72.8B AUM 32.97% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $111B AUM 30.48% 1-Year Est. Return
Braun Stacey Associates
Braun Stacey Associates New York $3.48B AUM 48.73% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Riverbridge Partners
Riverbridge Partners Minneapolis, Minnesota $3.41B AUM 6.54% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $113B AUM 26.61% 1-Year Est. Return

Barclays's GRDN Position: Q3 2026 in Review

Barclays increased its Guardian Pharmacy Services (GRDN) stake by 358% in Q3 2026, buying an estimated $487K and bringing the position to 15,279 shares worth $623K. The position accounts for ﹤0.01% of the portfolio, ranked #3346.

Barclays first reported a position in GRDN in Q3 2024 and has held it in 9 quarters since. The position peaked at $1.06M in Q4 2025. 88 funds tracked by Wall St. Rank hold GRDN as of Q3 2026.

  • Barclays held 15,279 shares of Guardian Pharmacy Services worth $623K as of Q3 2026.
  • Barclays bought 11,946 Guardian Pharmacy Services shares in Q3 2026, an estimated $487K.
  • Guardian Pharmacy Services made up ﹤0.01% of Barclays's portfolio in Q3 2026, its #3346 holding.
  • Barclays first reported a position in Guardian Pharmacy Services in Q3 2024 and has held it in 9 quarters since.
  • Barclays's Guardian Pharmacy Services position peaked at $1.06M in Q4 2025.
  • 88 funds tracked by Wall St. Rank held Guardian Pharmacy Services as of Q3 2026.

Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.